Macrogenics Inc (NASDAQ: MGNX) is -8.31% lower on its value in year-to-date trading and has touched a low of $2.79 and a high of $21.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MGNX stock was last observed hovering at around $2.85 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $2.98, the stock is -3.84% and -8.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.01 million and changing 4.56% at the moment leaves the stock -36.05% off its SMA200. MGNX registered -80.71% loss for a year compared to 6-month loss of -16.76%. The firm has a 50-day simple moving average (SMA 50) of $3.2568 and a 200-day simple moving average (SMA200) of $4.7255.
The stock witnessed a -13.87% gain in the last 1 month and extending the period to 3 months gives it a -23.00%, and is -1.65% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.89% over the week and 5.77% over the month.
Macrogenics Inc (MGNX) has around 339 employees, a market worth around $187.04M and $141.33M in sales. Profit margin for the company is -69.07%. Distance from 52-week low is 6.81% and -86.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-65.33%).
with sales reaching $30.93M over the same period.The EPS is expected to shrink by -697.81% this year, but quarterly earnings will post 168.88% year-over-year. Quarterly sales are estimated to grow 188.53% in year-over-year returns.
173.0 institutions hold shares in Macrogenics Inc (MGNX), with institutional investors hold 96.12% of the company’s shares. The shares outstanding are 62.76M, and float is at 57.88M with Short Float at 9.12%. Institutions hold 93.57% of the Float.
The top institutional shareholder in the company is BELLEVUE GROUP AG with over 9.94 million shares valued at $42.25 million. The investor’s holdings represent 15.9612 of the MGNX Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 6.0 million shares valued at $25.5 million to account for 9.6323 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.4 million shares representing 8.6718 and valued at over $22.96 million, while VANGUARD GROUP INC holds 6.6388 of the shares totaling 4.14 million with a market value of $17.58 million.
Macrogenics Inc (MGNX) Insider Activity
The most recent transaction is an insider sale by Peters Jeffrey Stuart, the company’s Senior VP and General Counsel. SEC filings show that Peters Jeffrey Stuart sold 51,395 shares of the company’s common stock on Apr 04 ’24 at a price of $15.55 per share for a total of $0.8 million. Following the sale, the insider now owns 0.0 shares.
Macrogenics Inc disclosed in a document filed with the SEC on Mar 06 ’24 that Peters Jeffrey Stuart (Senior VP and General Counsel) sold a total of 19,625 shares of the company’s common stock. The trade occurred on Mar 06 ’24 and was made at $21.50 per share for $0.42 million. Following the transaction, the insider now directly holds 8895.0 shares of the MGNX stock.
Still, SEC filings show that on Mar 04 ’24, Risser Eric Blasius (Chief Operating Officer) disposed off 41,159 shares at an average price of $19.76 for $0.81 million. The insider now directly holds 38,900 shares of Macrogenics Inc (MGNX).
